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Summary
 Background The concept of sentinel node biopsy has been widely invastigated in various malignant tumoures 
and has become a standard method in such neoplastic diseases as penile cancer or melanoma. In 
tumours, where the lymphatic ﬂ ow is more complicated and difﬁ cult to analyze, this concept still 
needs to be veriﬁ ed.
 Aim The aim of this paper is to present the validity of the above concept in sentinel node detection in 
vulvar, cervical and endometrial cancers.
 Materials/Methods Sentinel node detection was performed in 127 women with gynaecological malignances; 39 pa-
tients with vulvar cancer, 52 patients with cervical cancer and 36 patients with endometrial cancer. 
In sentinel node detection we used radioisotopes and a dye technique. After sentinel node dissec-
tion, in all cases, radical surgery with systemic lymphadenectomy was performed. The number and 
localization of the nodes classiﬁ ed as sentinel nodes were analyzed.
 Results The identiﬁ cation rate for sentinel node detection was 97.4% in vulvar cancer, 96.2% in cervical 
cancer and 88.9% in endometrial cancer. The sensitivity in this procedures was 100.0% in vulvar 
cancer, 94.0% in cervical cancer and 87.9% in endometrial cancer.
  Negative predictive value was 96.2% for vulvar cancer, 97.0% for cervical cancer and 100.0% for 
endometrial cancer.
 Conclusions The concept of sentinel node detection in gynaecological malignances requires more clinical date 
for its validation, but outcomes in vulvar cancer seem to be potentially most promising.
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BACKGROUND
The presence of metastases of neoplastic cells to lymph 
nodes, which are drained by lymph from the organ involved 
in neoplastic process, is one of the most important prognostic 
factors. Thus systemic pelvic and paraaortic, lymphadenec-
tomy in uterine and cervical cancer, as well as bilateral in-
quinal femoral and pelvic lymphadenectomy in vulvar can-
cer, remain the treatment of choice.
Dissection of the lymph nodes involved in neoplastic proc-
ess has two principle aims: it decreases the amount of tu-
mour mass with possible subsequent therapeutic effect, 
and it enables proper clinical staging of the neoplasm of 
the female genital tract and adequate planning of postop-
erative treatment.
These objectives make systemic lymphadenectomy the most 
important part of radical surgery.
Histologic analysis of lymph nodes of cancer patients, dis-
sected by radical surgery revealed metastases to the lymph 
nodes only in not more than 30% of all patients. Thus, 
more than 70% of patients, who underwent radical sur-
gery, do not beneﬁ t from this procedure [1]. Therefore, 
it is reasonable to limit the extensiveness of surgical pro-
cedures in those patients. Needless to say radical surgery 
in cancer patients is potentially a source of morbidity that 
includes an increase in blood loss, wound breakdown, in-
jury of large vessels and nerves, an increase in susceptibil-
ity to infections, formation of postoperative ﬁ stulas, lym-
phocoele, lymphoedema, restricted regional mobility, scar 
formation and further cosmetic, psychological and sexu-
al disturbances.
According to some authors, removal of unaffected lymph 
nodes may have an unfavorable effect on the local immu-
nological system, which may result in larger number of lo-
cal recurrences of the disease. The hypothesis based on this 
fact would make some clinicians more willing to limit the 
extensivness of surgery [1].
There are several visualization techniques used in the eval-
uation of lymph node status in female gynaecological ma-
lignancies. Unfortunately, none of them make it possible to 
comprehensively evaluate morphologically lymph node sta-
tus. In this context, there is considerable hope for progress in 
lymphatic mapping and sentinel node detection. According 
to Morton’s deﬁ nition, the sentinel node is a primary node 
which drains lymph directly from the tumour. Histological 
status of the sentinel node reﬂ ects the status of other lymph 
nodes in the regional lymphatic basin.
Sentinel node mapping using dyes and/or radioactive trac-
ers has already been successfully implemented as a stand-
ard procedure in penile cancer and melanoma and will be-
come, most probably, a standard procedure in breast cancer 
in the nearest future [2]. This has been possible because of 
the simplicity of the technique of mapping as well as a re-
sult of superﬁ cial lymphatic ﬂ ow patterns in those tumours. 
Actually, many centers gather experience in the detection 
of sentinel nodes in gynaecological malignances [3]. The 
accuracy of both techniques is evaluated as well as that of 
traditional or laparoscopic surgery [4–6].
AIM
The aim of this paper is to present the possibility of senti-
nel lymph node detection in vulvar, cervical and endome-
trial cancer, and to provide a response to the original con-
cept of sentinel node in those tumours.
MATERIALS AND METHODS
Lymphatic mapping and sentinel lymph node detection was 
performed in 127 women with gynaecological malignancies: 
39 patients with vulvar cancer stage I and II, 52 patients with 
cervical cancer stage IA2 to IIB, and in 36 patients with en-
dometrial cancer stage I, according to FIGO.
For sentinel node detection were used: 
1.  a radioisotope technique: Nanocoll (Nycomed Amersham 
Sorin S.r.l.) marked with technetium 99m, preoperative 
lymphoscyntygraphy and intraoperative detection by hand 
– held gamma probe (Navigator GPS, USSC), and
2.  a dye – Patent Blau (Guerbet GmbH) technique.
A radiotracer of 2,5 mCi activity was applied peritumora-
ly in vulvar and cervical cancer patients from 14 up to 18 
hours before planned surgery. In early advanced cervical 
cancers and in endometrial cancer, the radiotracer was in-
jected into 4 sites of the ectocervix: at 12, 3, 6 and 9 hours. 
Preoperative orientation of the lymphatic basin was based 
on lymphoscyntygraphy, performed 2 hours after radiotrac-
er injection. Then, intraoperatively, 2 to 4 ml of Patent Blau 
dye was injected, in the same way as was the radiotracer, 20–
30 minutes before planned lymphatic mapping. Additionally, 
in endometrial cancer cases, Patent Blau was injected sub-
serosly around the uterus fundus, and in the central of the 
anterior and posterior walls of the uterus (Table 1).
Sentinel lymph node(s) were searched for their tinge or ra-
diation emission, detected by a hand-held gamma probe, af-
ter obtaining access to the retroperitonium. Node(s) char-
acterized by 10 fold radiation emission to the surrounding 
background and a bluish tinge in compared to the other 
lymph nodes were qualiﬁ ed as sentinel nodes.
Then, all patients underwent radical surgery by systemic lym-
phodenectomy. The number and localization of the nodes 
classiﬁ ed as sentinel nodes were analyzed in each patient.
All the dissected lymph nodes were, then, examined by pa-
thologists, but sentinel nodes were additionally immuno-
histochemicaly stained for micrometastasis. The identiﬁ -
cation rate, sensitivity and the negative predictive value of 
the method were also determined.
RESULTS
In 39 patients with vulvar cancer, where both detection tech-
niques were used, accumulation of the radiotracer was re-
vealed in 38 (94.7%) cases (Table 2). Lymph nodes stained 
with blue dye were detected in 32 (82.1%) cases. In all cases, 
except one where the sentinel node was found in a region of 
deep inguinal lymph nodes, sentinel nodes were localized in 
a superﬁ cial inguinal lymph node group. Metastases to in-
guinal lymph nodes were found in 12 patients in complete 
agreement with the sentinel node status in these cases.
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In 52 women with cervical cancer, sentinel nodes were de-
tected using both techniques in 41 (78.8%) cases. In two 
(3.8%) cases the sentinel node was only blue stained; in 7 
(13.5%) cases only emission of the radiation was detected. 
In two cases both techniques failed.
Metastases to lymph nodes were found in 18 cases, but in 
one case sentinel nodes were found free of neoplastic cells. 
This case was classiﬁ ed as false negative.
In about 80% cases with metastases to lymph nodes, sen-
tinel nodes were located in the bifurcation of common il-
iac vessels.
Out of 36 patients with endometrial cancer both detection 
techniques were applied only in 13 cases. The remaining 23 
cases were mapped only by the dye technique. In 19 cases 
sentinel nodes were only stained, in two cases only emission 
of the radiation was detected, and in 11 cases both methods 
were efﬁ cient. In 4 women sentinel node detection failed. 
Metastases to lymph nodes were found in three patients, 
where sentinel nodes showed neoplastic cells as well.
The use of preoperative lymphoscyntygraphy has enable 
us to establish approximate localization of sentinel nodes 
in all cases.
DISCUSSION
The concept of a sentinel nodes has created a new quality in 
optimizing lymphatic system evaluation, and may bring about 
positive clinical results. Most probably, in many cases systemic 
lymphodenectomy will be replaced by selective lymphodenec-
tomy [1]. This make it possible to limit the number of lymph 
node dissections, reduce the extent of surgery and, as a con-
sequence, the number of perioperative complications. Based 
on our data, it seems that lymphatic mapping and detection 
of sentinel nodes in vulvar cancer may become well accepted 
[7–9]. This is due to the uncomplicated lymphatic basin and 
the simplicity of the technique. Lymphatic pathways in cervical 
and endometrial cancer are much more complicated [10,11]. 
The standardization of the technique, especially in endometrial 
cancer unlike tumours, will also be more difﬁ cult [12]. Judging 
from preliminary data, the best results could be obtained us-
ing both, the dye and the radioactive methods simultaneous-
ly. Moreover, it seems that preoperative lymphoscyntygraphy 
would improve surgeon’s knowledge of the location of senti-
nel nodes. On the other hand, sentinel node biopsy is a mini-
mal invasive technique which efﬁ cacy depends on experience 
and quality of surgery team. Thus, it may put in different light 
the place of laparoscopic surgery in gynaecological oncology, 
where it becomes possible obtaining larger magniﬁ cation and 
where instrumentations allow become more precise.
CONCLUSIONS
The concept of sentinel nodes in gynaecological malignan-
cies needs clinical conﬁ rmation for every kind of tumour. It 
also requires determination of false negative results, which 
may have an impact on clinical results.
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Method of detection Vulvar cancer Cervical cancer Endometrial cancer
Patent Blau (1) – – 23
Radiotracer (2) – – –
Both (1+2) 39 52 13
Total 39 52 36
Table 1. Lymphatic mapping and sentinel node detection techniques.
Method of detection Vulvar cancern/N(%)
Cervical cancer
n/N(%)
Endometrial cancer*
n/N(%)
1. Only stained (1)
2. Only radiation emission (2)
3. Both (1+2)
4. All cases with identifi ed sentinel node(s) (1+2+3)
5. Identifi cation failure
6. Total
–
 6/39 (15.4)
 32/39 (82.1)
 38/39 (97.4)
 1/39 (2.6)
 39 (100.0)
 2/52 (3.8)
 7/52 (13.5)
 41/52 (78.8)
 50/52 (96.2)
 2/52 (3.8)
 52 (100.0)
 19/36
 2/13
 11/13
 32/36 (88.9)
 4/36 (11.1)
 36 (100.0)
7. Identifi cation rate
8. Sensitivity
9. NPV
 97.4
 100.0
 96.2
 96.2
 94.0
 97.0
 88.9
 87.9
 100.0
Table 2. Results of lymphatic mapping and sentinel node detection in vulvar, cervical and endometrial cancer.
* Radiotracer was used in 13 cases;
NPV – negative predictive value.
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